These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26377148)

  • 1. Investigation of Rho-Kinase Expressions and Polymorphisms in Mantle Cell Lymphoma Patients.
    Yanardağ Açık D; Yılmaz M; Sarı İ; Öztuzcu S; Sayıner ZA; Subari S; Demiryürek AT
    Turk J Haematol; 2016 Jun; 33(2):141-7. PubMed ID: 26377148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of rho-kinase gene polymorphisms and protein expressions in colorectal cancer development.
    Sari I; Berberoglu B; Ozkara E; Oztuzcu S; Camci C; Demiryurek AT
    Pathobiology; 2013; 80(3):138-45. PubMed ID: 23328676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Rho/Rho-kinase gene polymorphisms and expressions with obesity-related metabolic syndrome.
    Tabur S; Oztuzcu S; Oguz E; Korkmaz H; Eroglu S; Ozkaya M; Demiryürek AT
    Eur Rev Med Pharmacol Sci; 2015; 19(9):1680-8. PubMed ID: 26004609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between Rho-kinase (ROCK2) gene polymorphisms and Behçet's disease.
    Oguz E; Alasehirli B; Pehlivan Y; Onat AM; Oztuzcu S; Ozkara E; Kisacik B; Camci C; Demiryürek AT
    Transl Res; 2012 Dec; 160(6):428-34. PubMed ID: 22939913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCL1 expression predicts overall survival in patients with mantle cell lymphoma.
    Shin SJ; Roh J; Cha HJ; Choi YD; Kim JM; Min SK; Kim JE; Eom DW; Lee H; Kim HJ; Yoon DH; Suh C; Huh J
    Eur J Haematol; 2015 Dec; 95(6):583-94. PubMed ID: 25688912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2012 Jun; 87(6):604-9. PubMed ID: 22615102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Composite lymphoma cosisting of mantle cell lymphoma and follicular lymphoma].
    Matsuoka A; Tsushima T; Tanibuchi M; Katsuki N; Kushida Y; Takata K; Taoka T
    Rinsho Ketsueki; 2013 Nov; 54(11):2056-61. PubMed ID: 24305539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ hybridization and reverse transcription-polymerase chain reaction for cyclin D1 mRNA in the diagnosis of mantle cell lymphoma in paraffin-embedded tissues.
    Athanasiou E; Kotoula V; Hytiroglou P; Kouidou S; Kaloutsi V; Papadimitriou CS
    Mod Pathol; 2001 Feb; 14(2):62-71. PubMed ID: 11235907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of cyclin D1 protein expression and t(11;14) chromosomal translocation in paraffin-embedded tissues and its clinicopathologic significance for mantle cell lymphoma].
    Shui RH; Yang WT; Sun MH; Shi DR; Zhu XZ
    Zhonghua Bing Li Xue Za Zhi; 2003 Aug; 32(4):337-41. PubMed ID: 14514379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma.
    Islam TC; Asplund AC; Lindvall JM; Nygren L; Liden J; Kimby E; Christensson B; Smith CI; Sander B
    Leukemia; 2003 Sep; 17(9):1880-90. PubMed ID: 12970790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mantle cell lymphoma in the ocular adnexal region.
    Looi A; Gascoyne RD; Chhanabhai M; Connors JM; Rootman J; White VA
    Ophthalmology; 2005 Jan; 112(1):114-9. PubMed ID: 15629830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau.
    Eskelund CW; Kolstad A; Jerkeman M; Räty R; Laurell A; Eloranta S; Smedby KE; Husby S; Pedersen LB; Andersen NS; Eriksson M; Kimby E; Bentzen H; Kuittinen O; Lauritzsen GF; Nilsson-Ehle H; Ralfkiaer E; Ehinger M; Sundström C; Delabie J; Karjalainen-Lindsberg ML; Workman CT; Garde C; Elonen E; Brown P; Grønbaek K; Geisler CH
    Br J Haematol; 2016 Nov; 175(3):410-418. PubMed ID: 27378674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible Gender-Related Modulation by the ROCK1 Gene in Colorectal Cancer Susceptibility.
    Zucchini C; Martinelli M; De Sanctis P; Rodia MT; Mattei G; Ugolini G; Montroni I; Ghignone F; Solmi R
    Pathobiology; 2015; 82(6):252-8. PubMed ID: 26562026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
    Rasmussen PK
    Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mantle cell lymphoma in Taiwan: clinicopathological and molecular study of 21 cases including one cyclin D1-negative tumor expressing cyclin D2.
    Chuang SS; Huang WT; Hsieh PP; Tseng HH; Campo E; Colomer D; Ye H; Lu CL; Chang HM; Cho CY; Huang SH; Lu YC; Wu JD
    Pathol Int; 2006 Aug; 56(8):440-8. PubMed ID: 16872438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoic acid inhibits the proliferative response induced by CD40 activation and interleukin-4 in mantle cell lymphoma.
    Guidoboni M; Zancai P; Cariati R; Rizzo S; Dal Col J; Pavan A; Gloghini A; Spina M; Cuneo A; Pomponi F; Bononi A; Doglioni C; Maestro R; Carbone A; Boiocchi M; Dolcetti R
    Cancer Res; 2005 Jan; 65(2):587-95. PubMed ID: 15695403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-multiple lymphomatous polyposis form of mantle cell lymphoma in the gastrointestinal tract.
    Tamura S; Ohkawauchi K; Yokoyama Y; Higashidani Y; Daibata M; Hiroi M; Yamamori S; Onishi S
    J Gastroenterol; 2004 Oct; 39(10):995-1000. PubMed ID: 15549454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential PAX5 levels promote malignant B-cell infiltration, progression and drug resistance, and predict a poor prognosis in MCL patients independent of CCND1.
    Teo AE; Chen Z; Miranda RN; McDonnell T; Medeiros LJ; McCarty N
    Leukemia; 2016 Mar; 30(3):580-93. PubMed ID: 26073757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.